Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Ganesha, I dont have a single link to show that Dr

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155408
(Total Views: 672)
Posted On: 10/15/2020 8:20:50 PM
Posted By: havasu78
Re: Ganesha #61323
Ganesha, I dont have a single link to show that Dr. Seethamraju bulldozed the FDA into approving LL despite an absence of clinical studies and also despite the FDA scientists' belief that leronlimab had no application to leronlimab.

i don't think that there exists a single document or interview which relates all of the details.

At least twicein interviews or conference calls, Pourhassan has explained that Cytodyn requested to use leronlimab on covid patients way back in March and the FDA said "No, you have to do some preclinical studies."

So the FDA categorically denied Cytodyn's request to try leronlimab on covid.

Without a doubt, there are no preclinical leronlimab studies for covid. They do not exist. And that is the basis for the FDA's denial to try LL in covid.

Enter Dr. Seethamraju. At least three times in conference calls or interview, Pourhassan explained that Dr. Seethamraju solicited the FDA to use LL on two of his terminal patients. Dr. Seethamraju's FDA solicitation occurred after the FDA had already declined Cytodyn's request to try LL in covid.

Somehow or other, Dr. Seethamraju prevailed in his solicitation of the FDA, and the FDA agreed to let Dr. Seethamraju try LL on two terminal covid patients.

A key question that has never been answered, maybe even never asked, is:

Why was Dr. Seethamraju able to prevail at the FDA where Cytodyn could not? Of course Dr. Seethamraju was watching his patients die, so there is that.

When the first two patients responded postively to lernlimab, the EIND floodgates opened for LL.

This story, told several times by Pourhassan, is why Pourhassan calls Seethamraju the "hero doctor".

Also told in the story at least twice by Pourhassan is the part that the FDA did not believe leronlimab would do anything for covid. There was no mechanism of action.

Its not surprising that the FDA scientists believed LL had no application to covid because at that time, Patterson's preprint was obviously not published. Patterson and others must have had the idea, but it was just an idea and a pretty new one at that. RANTES signalling as a contribution to covid deaths was not widely known, let alone believed, by many people.

Perhaps Dr. Bruce Patterson played some sort of key role supporting Dr. Seethamraju's solicitaion of the FDA, but the way Seethamraju is going it looks like he may not need help from anyone

A google search for " seethamraju 'hero doctor' " gets a few hits so you might be able to start there.


(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us